Literature DB >> 12528771

Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease.

Peter J Roberts1, Burton Eisenberg.   

Abstract

Gastrointestinal stromal tumors (GISTs) are generally found in the stomach or small intestine and less commonly in the colon, rectum or an intra-abdominal site. The patients symptoms on presentation are most commonly gastrointestinal bleeding. Surgery remains the standard treatment for nonmetastatic GISTs, but rates of disease recurrence are significant--5% in primary disease and 90% in locally advanced disease. Five-year survival following surgical resection varies between 35% and 65% on the basis of several published studies. Clinical knowledge of the prognosis of patients with GISTs remains rather limited--small tumor size, low-grade mitotic index and stomach location are factors associated with a more favorable prognosis.

Entities:  

Mesh:

Year:  2002        PMID: 12528771     DOI: 10.1016/s0959-8049(02)80601-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  50 in total

Review 1.  Gastrointestinal stromal tumors (GISTs): an updated experience.

Authors:  Anastasios Machairas; Eva Karamitopoulou; Dimitrios Tsapralis; Theodore Karatzas; Nickolas Machairas; Evangelos P Misiakos
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

2.  Surgical margin status and prognosis of gastrointestinal stromal tumor.

Authors:  António M Gouveia; Amadeu P Pimenta; Ana F Capelinha; Dionísio de la Cruz; Paula Silva; José M Lopes
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

Review 3.  Gastrointestinal stromal tumours: advances in surgical and pharmacological management options.

Authors:  Amitabh Thacoor
Journal:  J Gastrointest Oncol       Date:  2018-06

4.  Outcomes After Surgical Resection Differ by Primary Tumor Location for Metastatic Gastrointestinal Stromal Tumors (GISTs): a Propensity Score Matching Population Study.

Authors:  Apostolos Gaitanidis; Michail Alevizakos; Alexandra Tsaroucha; Michail Pitiakoudis
Journal:  J Gastrointest Cancer       Date:  2019-12

5.  Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables.

Authors:  Haluk R Unalp; Hayrullah Derici; Erdinc Kamer; Ali D Bozdag; Ercument Tarcan; Mehmet A Onal
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

6.  Clinicopathological study of 113 gastrointestinal stromal tumors.

Authors:  Rahul Bhalgami; Kak Manish; Prachi Patil; Shaesta Mehta; K M Mohandas
Journal:  Indian J Gastroenterol       Date:  2012-12-08

7.  Neoadjuvant imatinib: longer the better, need to modify risk stratification for adjuvant imatinib.

Authors:  Anant Ramaswamy; Deepak Jain; Arvind Sahu; Joydeep Ghosh; Priya Prasad; Kedar Deodhar; Nitin Shetty; Shripad Banavali; Shailesh Shrikhande; Vikas Ostwal
Journal:  J Gastrointest Oncol       Date:  2016-08

8.  Stromal duodenal tumor revealed by an acute pancreatitis: report of a case.

Authors:  Mehdi Soufi; Bouziane Chad
Journal:  J Gastrointest Cancer       Date:  2010-03

9.  Gastrointestinal stromal tumors (GIST): a prospective evaluation of risk factors and prognostic scores.

Authors:  Juan Manuel Sanchez Hidalgo; Sebastian Rufian Peña; Ruben Ciria Bru; Alvaro Naranjo Torres; Cristobal Muñoz Casares; Juan Ruiz Rabelo; Javier Briceño Delgado
Journal:  J Gastrointest Cancer       Date:  2010-03

10.  Clinical outcomes of gastrointestinal stromal tumor in southern Thailand.

Authors:  Kittima Pornsuksiri; Siripong Chewatanakornkul; Samornmas Kanngurn; Wanwisa Maneechay; Walawee Chaiyapan; Surasak Sangkhathat
Journal:  World J Gastrointest Oncol       Date:  2012-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.